Accelmed is a global group of funds investing in HealthTech companies (medical device, diagnostics and digital health) across all stages. It currently invests through two separate arms: Accelmed Partners a US-based lower market private equity HealthTech fund, focused on Buyout and Growth Investments in commercial HealthTech (>$10M LTM) companies; and, Accelmed Ventures an Israel based venture fund, focused on pre-commercialization and early revenue HealthTech Opportunities. Accelmed Partners is acquiring commercial HealthTech companies and fostering significant value creation by supporting management teams, driving innovation, providing growth capital and potentially integrating innovative add-on technologies, largely from Israel. Accelmed Partners targets equity investments of $10-50M per transaction. Accelmed Ventures aims to create successful medical device and digital health companies by using its deep expertise, extensive network and proven track record. It focuses on medical devices and digital health companies with exceptional leading teams; innovative solutions addressing unmet needs in major chronic disease areas such as neurodegenerative, oncology, metabolic and cardiovascular diseases; and companies with a proven clinical concept and/or a proven business model.